Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort

Conditions:   Invasive Mammary Carcinoma;   Metastatic Breast Cancer Interventions:   Drug: Capecitabine;   Other: Endocrine-therapy;   Other: MammoPrint ® and BluePrint assays Sponsors:   Sonya Reid;   Agendia;   Susan G. Komen Breast Cancer Foundation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials